Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NITROGLYCERIN vs NIVOLUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NITROGLYCERIN vs NIVOLUMAB: Safety Overview

Metric NITROGLYCERIN NIVOLUMAB
Total FAERS Reports 7,431 87,742
Deaths Reported 962 23,086
Death Rate 12.9% 26.3%
Hospitalizations 3,185 36,530
Average Patient Age 69.7 yrs 64.2 yrs
% Female Patients 63.8% 34.0%
FDA Approval Date Approved Prior to Jan 1, 1982 N/A
Manufacturer Boiron E.R. Squibb & Sons, L.L.C.
Route ORAL INTRAVENOUS
Marketing Status Discontinued Prescription